What are the significant challenges facing your industry today?
This is a loaded question. However, based on BIOMED’s focus on clinical research we’ll focus on and our team’s perspective at BIOMED, the following are some significant challenges facing clinical research in the healthcare industry today.
Patients must be at the center of the process with the rise of decentralized clinical trials (DCTs). As patients adapt to flexible solutions in healthcare, companies must ensure that the benefits of decentralized clinical trials, such as reducing patient burden and providing flexibility, continue to be prioritized. This involves integrating decentralized elements into the standard design of trials.
Get Bobby D. Ntoya, MBA’s stories in your inbox
Join Medium for free to get updates from this writer.
The COVID-19 pandemic underlined the importance of diversity in clinical trials. Everyone acknowledges a lack of diversity in clinical trial participants, and with the passing of the NIH Clinical Trial Diversity Act of 2022, there’s a growing push to solve this problem. In addition, this includes the following regulatory guidelines like those provided by the FDA for improving clinical trial diversity.
The goal is for companies to keep pace with the advances and integrate them into their operations as technology evolves. For example, wearable technologies and artificial intelligence (AI) have significantly expanded. Moreover, technologies such as health data spaces and blockchain present new opportunities for the industry.
Staffing issues and economic pressures pose significant hurdles. With the ongoing great resignation, there are potential skills shortages, and many companies are reevaluating their outsourcing models. Additionally, rising energy costs and high inflation present economic challenges that could curb investment and slow down innovation as companies have to focus more on profitability.
In summary, despite these challenges, we at BIOMED have a sense of optimism within the company. We are committed to leveraging technology and increasing diversity, thus placing patients at the core of healthcare and clinical research.
